Neurocrine Says Sleeping Pill Data Are Good

Neurocrine Biosciences (NBIX Quote) said Thursday that results from the first late-stage study of its experimental sleeping pill proved the drug to be effective and safe in patients with transient insomnia.

Results from the 593-patient, phase III clinical trial demonstrated that a capsule formulation of the drug Indiplon allowed people to fall asleep quickly without feeling drowsy the following day. The study achieved statistically significant results in both its primary and secondary endpoints, which used machines to measure objectively the onset and quality of a person's sleep. ...